The deeper threat to the biopharmaceutical industry may come not from macro-level disruption, but from structural pressures ...

How AI and other digital tools are progressing across the bio/pharmaceutical industry is on top of mind. Key perspectives on ...

A recent KPMG study of more than 1,300 CEOs at large companies globally, including 400 US companies, say supply-chain cost ...

Merck KGaA has agreed to acquire Silence Therapeutics, a Cambridge, UK-based clinical-stage bio/pharmaceutical company developing short interfering RNA (siRNA) medicines, for $1.3 billion, ...

Sanofi has broken ground on a new insulin manufacturing facility in Frankfurt, Germany. The new facility will be built on a 36,000-square-meter footprint at the Sanofi BioCampus in Frankfurt.

The Board of Directors of CSL, a Melbourne, Australia-based bio/pharmaceutical company, has appointed Deborah Waterhouse, currently Chief Executive Officer (CEO) of ViiV Healthcare, a joint venture ...

What are key trends for injectable drugs and the related market impact? From switches from IV-administered to subcutaneous ...

Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view all ...

The global CMDO market for peptides and oligonucleotides (TIDES) is showing strong growth, fueled by new drug development, particularly for peptide-based drugs. The global CDMO market for peptides and ...

With the blockbuster success of its Type 2 diabetes/obesity drugs, Mounjaro/ Zepbound (tirzepatide), and more blockbuster potential in its Type 2 diabetes/obesity drug franchise with Foundayo ...